<DOC>
<DOCNO>
EP-0006227
</DOCNO>
<TEXT>
<DATE>
19800109
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/395 A61K-31/165 C07D-295/00 C07D-295/192 C07D-295/12 C07D-295/18 C07D-295/13 <main>C07C-149/41</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives.
</TITLE>
<APPLICANT>
kyowa hakko kogyo kk jp  <sep>kyowa hakko kogyo co., ltd<sep>kyowa hakko kogyo co., ltdohtemachi bldg., ohtemachi 1-chomechiyoda-ku, tokyojp<sep>kyowa hakko kogyo co., ltd<sep>
</APPLICANT>
<INVENTOR>
hashimoto tamotsu<sep>murayama yo<sep>naruse masao<sep>niino hideke<sep>yamada koji<sep>hashimoto, tamotsu<sep>murayama, yo<sep>naruse, masao<sep>niino, hideke<sep>yamada, koji<sep>hashimoto, tamotsu1188, shimotogari nagaizumi-chosunto-gun shizuoka-kenjp<sep>murayama, yo4-17-6, nakazato minami-kuyokohama-shi kanagawa-kenjp<sep>naruse, masao870-51, kamitsuchidana ayase-shikanagawa-kenjp<sep>niino, hideki376, kumizawa-cho totsuka-kuyokohama-shi kanagawa-kenjp<sep>yamada, koji1188, shimotogari nagaizumi-chosunto-gun shizuoka-kenjp<sep>hashimoto, tamotsu  <sep>murayama, yo <sep>naruse, masao<sep>niino, hideki<sep>yamada, koji<sep>hashimoto, tamotsu1188, shimotogari nagaizumi-chosunto-gun shizuoka-kenjp<sep>murayama, yo4-17-6, nakazato minami-kuyokohama-shi kanagawa-kenjp<sep>naruse, masao870-51, kamitsuchidana ayase-shikanagawa-kenjp<sep>niino, hideki376, kumizawa-cho totsuka-kuyokohama-shi kanagawa-kenjp<sep>yamada, koji1188, shimotogari nagaizumi-chosunto-gun shizuoka-kenjp<sep>
</INVENTOR>
<ABSTRACT>
the invention relates to antithrombotic agents of for­ mula    wherein x₁ und x₂ may de hydrogen, halogen, hydroxy­ nitro, cyano, amino, lower alkyl or alkoxy, r₁ und r₂ may  be amino, alkylamino, dialkylamino, arylamino or diaryl­ amino, napthylamino, aralkylamino, mono-, di- or tri-hy­ droxyalkylamino, piperidinylakylamino, alkoxy alkylamino,  dialkyloxyalkylamino, acyloxyalkylamino, hydroxylamino­ alkylamino or pharmaceutical salts thereof.  these agents have the ability to suppress aggrega­ tion of blood platelets.  
</ABSTRACT>
</TEXT>
</DOC>
